GFAP-CreERT2 for astrocyte conditional models
A floxed Target allele paired with Cre gives spatial control that whole body knockouts cannot offer. Labs use this approach to separate developmental roles from adult homeostasis, to model human somatic mutations, and to align with clinical presentations where disease begins in one organ. For astrocyte work, plan Cre specificity, reporter crosses, and baseline phenotyping before you scale.
Driver pairing notes
GFAP-CreERT2 biases recombination toward astrocyte lineages. Inducible design: yes, via tamoxifen.
Conditional knockout keeps astrocyte as the experimental theater while the rest of the animal retains a wild type allele. That pattern mirrors somatic mutation in patients and avoids systemic compensation that can erase subtle phenotypes. It is often preferred when a germline null is lethal, weak, or confounded by developmental rescue.
A conventional knockout answers whether the gene is required broadly. When astrocyte is the organ of interest, a global null can still be informative if viability is acceptable and you want the simplest genotype. If the null is harsh, a floxed allele with a regional Cre is the safer long term platform.
Example conditional alleles to pair with GFAP-CreERT2
Frequently asked questions
What animals express GFAP-CreERT2?
GFAP-CreERT2 is used for astrocyte biased recombination in community standard protocols. We recommend reporter validation on your background before large experiments.
Is GFAP-CreERT2 inducible?
Some lines in the CreERT2 family need tamoxifen for nuclear access. Tell us your timing goals and we help pick tamoxifen versus constitutive strategies.
Which floxed genes pair with GFAP-CreERT2?
Top pairs depend on your disease model. We link common conditional alleles in our catalog and can suggest three to five references genes that match astrocyte biology.